Results 91 to 100 of about 662,107 (171)
Carcinoid tumors of the lung: A report of 11 cases
Carcinoid tumors of the lung are rare, and account for 1% of all primary tumors of the lung. This study was undertaken to investigate the histological characteristics and clinical behavior of carcinoid tumors of the lung. We have retrospectively reviewed
Mitsuhiro Takenoyama, Mitsuhiro Takenoyama +3 more
core
Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors
Purpose: Pulmonary carcinoid tumors account for up to 5% of all lung malignancies in adults, comprise 30% of all carcinoid malignancies, and are defined histologically as typical carcinoid (TC) and atypical carcinoid (AC) tumors.
Marie Christine Aubry +13 more
core +1 more source
ANALYSIS OF THE OUTCOMES OF SURGICAL TREATMENT IN PATIENTS WITH BRONCHOPULMONARY CARCINOID TUMORS
Inroduction. Surgical resection of bronchopulmonary carcinoid tumors remains the primary treatment modality and provides good outcomes. There exists debate, however, about the optimal extent of resection for this disease.
Ivan Z. Vytvytskyi +5 more
doaj +1 more source
Gastrointestinal peptide hormone receptors, like somatostatin receptors, are often overexpressed in human cancer, allowing receptor-targeted tumor imaging and therapy.
Hayes, Gregory M +5 more
core +1 more source
Emerging Immunotherapeutic and Diagnostic Modalities in Carcinoid Tumors. [PDF]
Vellani SD +4 more
europepmc +1 more source
Carcinoid tumors: Challenges and considerations during anesthetic management
Carcinoid tumors are rare, slow-growing neoplasms of neuroendocrine tissues from enterochromaffin or kulchitsky cells, which have the potential to metastasize.
Aparajita Panda +2 more
core +1 more source
Growth Rates of Pulmonary Carcinoid Tumors and Hamartomas. [PDF]
Ryan JW, Hammer MM.
europepmc +1 more source
Pulmonary neuroendocrine tumors are rare, accounting for approximately 1% to 2% of lung cancers. Atypical carcinoids account for approximately 10% of pulmonary neuroendocrine tumors and are categorized as moderately malignant.
Masafumi Saiki, MD +10 more
doaj +1 more source
Survival Benefit of Adjuvant Chemotherapy in Pulmonary Carcinoid Tumors. [PDF]
Sobash PT, Ullah A, Karim NA.
europepmc +1 more source
Background Carcinoid tumors are rare neuroendocrine malignancies presenting in an increasing number in our center. The incidence of carcinoid tumors is approximatively between 2.5 and 5 cases per 100,000 people of whom about 50% develop carcinoid ...
Kevin Van Ussel +3 more
doaj +1 more source

